All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Peptides for depression and anxiety: what the science says

David DeMesquita™️

TikTok creator

65.5K viewsWatch on TikTok→

Quick answer

Semax and selank are synthetic peptides studied primarily in Russian preclinical and small clinical research for cognitive enhancement and anxiolytic effects, respectively. Neither compound holds FDA approval, and their proposed mechanisms involving BDNF upregulation and GABAergic modulation remain incompletely characterized in peer-reviewed human trials. Any therapeutic application should be supervised by a licensed clinician with access to a patient's complete medical and psychiatric history.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.

What did @daviddemesquita actually say?

The creator's core claim is that semax and selank should not be taken together, not because they're dangerous in combination, but because they serve opposite purposes and are better used situationally. He says semax "drives up dopamine levels" and BDNF to support mood and motivation, while selank calms anxiety through GABA pathways, similar in spirit to gabapentin. He warns that most TikTok peptide content is just ChatGPT output read aloud by people who don't understand the pharmacology.

To his credit, he's not saying this is a dangerous combination. His actual position is more nuanced: these peptides work better when deployed strategically rather than stacked together every day. That's a reasonable therapeutic philosophy, even if some of his mechanistic explanations don't fully hold up under scrutiny.

Does the science back this up?

Partly, but with important caveats. Semax is a synthetic heptapeptide derived from ACTH, studied primarily in Russian research. It does appear to influence BDNF expression, which is the "BDF" the creator likely meant. Dolotov et al. (2006, Journal of Molecular Neuroscience) found semax increased BDNF mRNA in rat brain tissue. Dopamine modulation is less direct and more speculative in the human literature.

Selank is a synthetic analog of tuftsin, and Russian clinical work, including Zozulya et al. (2001, Bulletin of Experimental Biology and Medicine), suggests it has anxiolytic effects and may interact with the GABAergic system. However, calling it a straightforward GABA-booster the way gabapentin works is an oversimplification. Gabapentin binds to voltage-gated calcium channels, not GABA receptors directly, and selank's mechanism is not equivalent. The comparison is illustrative but imprecise.

No peer-reviewed human trials exist on co-administration of semax and selank. This is a significant gap. The creator is offering a theoretical rationale, not evidence-based guidance.

What did they get wrong (or right)?

The creator gets credit for pushing back on the "just mix everything" culture on TikTok. The instinct that combining a stimulating peptide with a calming one might blunt the effect of both is pharmacologically reasonable, even if the supporting evidence is thin.

Where he goes wrong: the gabapentin comparison is misleading. He frames selank and gabapentin as working through shared GABA mechanisms, implying similar effects. Gabapentin's primary action is on alpha-2-delta subunits of calcium channels, not direct GABA receptor agonism. Selank's proposed anxiolytic mechanism involves enkephalin degradation inhibition and possible serotonin modulation, not just GABA. Collapsing these into the same category misrepresents both compounds.

The dopamine claim for semax is also presented with more certainty than the evidence warrants. Most semax research is preclinical or from small Russian trials. Saying it "drives up dopamine" as a confident mechanism overstates what's established in the literature for humans.

  • Right: situational use over daily stacking is a defensible approach
  • Right: BDNF connection to semax has some research support
  • Wrong: the gabapentin-selank equivalence is an oversimplification
  • Wrong: dopamine mechanism stated with more confidence than evidence allows
  • Unverifiable: the "you don't want balance" framing has no clinical basis

What should you actually know?

Both semax and selank are research peptides. Neither has FDA approval for any indication. The overwhelming majority of data on these compounds comes from Soviet-era and Russian Federation research, which, while not worthless, has not been replicated in large Western randomized controlled trials. Anyone presenting confident mechanistic claims about these peptides for human neurochemistry is working well ahead of the available evidence.

The creator's practical advice, using an activating peptide in the morning and a calming one in the evening as needed, is not harmful framing. But it should be understood as a clinical hypothesis, not established protocol. If you're considering either peptide, that conversation belongs with a licensed provider who can assess your full health picture, not a TikTok comment thread or a ChatGPT session.

The irony is that the creator criticizes others for copying ChatGPT while himself presenting mechanistic claims that lack rigorous human trial support. That doesn't make him wrong about everything, but it's worth noting.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 5 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For Peptides for depression and anxiety: what the science says, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

Peptides for depression and anxiety: what the science says is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

Compare providers, services and access requirements in the directory before contacting a suitable care team.

Claim verdict

The useful answer behind this video

Claim being checked

Semax and selank are synthetic peptides studied primarily in Russian preclinical and small clinical research for cognitive enhancement and anxiolytic effects, respectively.

FormBlends verdict

Semax and selank are synthetic peptides studied primarily in Russian preclinical and small clinical research for cognitive enhancement and anxiolytic effects, respectively. Neither compound holds FDA approval, and their proposed mechanisms involving BDNF upregulation and GABAergic modulation remain incompletely characterized in peer-reviewed human trials. Any therapeutic application should be supervised by a licensed clinician with access to a patient's complete medical and psychiatric history.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Semax and selank are synthetic peptides studied primarily in Russian preclinical and small clinical research for cognitive enhancement and anxiolytic effects, respectively. Neither compound holds FDA approval, and their proposed mechanisms involving BDNF upregulation and GABAergic modulation remain incompletely characterized in peer-reviewed human trials. Any therapeutic application should be supervised by a licensed clinician with access to a patient's complete medical and psychiatric history.
  • Neither semax nor selank holds FDA approval for any medical indication as of 2024. Both are research peptides with limited large-scale human trial data.
  • Semax's strongest research support involves BDNF expression, not direct dopamine elevation. Dolotov et al. (2006) showed effects in rodents, but human data is sparse.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Neither semax nor selank holds FDA approval for any medical indication as of 2024. Both are research peptides with limited large-scale human trial data.
  • Semax's strongest research support involves BDNF expression, not direct dopamine elevation. Dolotov et al. (2006) showed effects in rodents, but human data is sparse.
  • Selank's mechanism is not equivalent to gabapentin's. Gabapentin acts on calcium channel subunits; selank's proposed effects involve enkephalin pathways and possibly serotonin, per Zozulya et al. (2001).
  • The creator's core recommendation, using activating and calming peptides situationally rather than stacking them daily, is a reasonable clinical hypothesis but is not validated by controlled trials.
  • Most semax and selank studies originate from Russian research institutions and have not been replicated in large Western randomized controlled trials, which limits their applicability to clinical guidance.
  • Anyone considering these peptides should consult a licensed telehealth provider or physician, not base decisions on TikTok content or AI chatbot output, regardless of how confident the presenter sounds.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

David DeMesquita™️ · TikTok creator

65.5K views on this video

Replying to @Shauna #depression #anxiety #peptide

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by David DeMesquita™️, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.